New Zealand government bonds close tad higher Tuesday even as market participants are anticipating a slight rise in the country’s gross domestic product (GDP) for the fourth quarter of last year, scheduled to be released on March 14 by 21:45GMT.
At the time of closing, the yield on the benchmark 10-year Treasury note, which moves inversely to its price, slid 1/2 basis point to 2.99 percent, the yield on 20-year also slipped 1/2 basis point to 3.49 percent and the yield on short-term 2-year too closed 1/2 basis point lower at 1.97 percent.
Economic growth is expected to remain moderate but concerns of a slowdown are mounting as New Zealand’s economy moves further into the late cycle of its growth. Economists are picking last year’s fourth quarter GDP growth to come in between 0.6 percent-0.8 percent when figures are released on Thursday.
Westpac, whose 0.6 percent forecast is the most bearish of the major banks, says the fourth quarter of last year was just an average few months for the economy.
Meanwhile, the NZX 50 index closed 0.11 percent higher at 8,473.14, while at 06:00GMT, the FxWirePro's Hourly NZD Strength Index remained highly bullish at 151.04 (a reading above +75 indicates a bullish trend, while that below -75 a bearish trend). For more details, visit http://www.fxwirepro.com/currencyindex
FxWirePro launches Absolute Return Managed Program. For more details, visit http://www.fxwirepro.com/invest


Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
FxWirePro: Daily Commodity Tracker - 21st March, 2022
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



